Search Within

Christopher G Azzoli

  1. "Clinical Cancer Research"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Thoracic Oncology (8)
  4. Radiology, Department of (6)
  5. Body Imaging Service (5)
  6. Department of Pathology and Laboratory Medicine (4)

More Groups

People
  1. Mark Kris (8)
  2. Vincent Miller (7)
  3. Lee Krug (6)
  4. Michelle Ginsberg (5)
  5. Gregory Riely (4)
  6. William Pao (4)

More People

Years
  1. 2012 (1)
  2. 2011 (3)
  3. 2010 (1)
  4. 2007 (1)
  5. 2003 (2)
Publications
  1. Clinical Cancer Research (8)
Publishers
  1. American Association for Cancer Research (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarker
    Journal Article

    Pietanza, M. C.; Kadota, K.; Huberman, K.; Sima, C. S.; Fiore, J. J.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; Holodny, A. I.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
    Journal Article

    Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Sima, C. S.; Kass, S. L.; Riely, G. J.; Pao, W.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene
    Journal Article

    Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib
    Journal Article

    Janjigian, Y. Y.; Azzoli, C. G.; Krug, L. M.; Pereira, L. K.; Rizvi, N. A.; Pietanza, M. C.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Analysis of genetic variants in never-smokers with lung cancer facilitated by an internet-based blood collection protocol: A preliminary report
    Journal Article

    Girard, N.; Lou, E.; Azzoli, C. G.; Reddy, R.; Robson, M.; Harlan, M.; Orlow, I.; Yatabe, Y.; Nafa, K.; Ladanyi, M.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Gomez, J.; Miller, V. A.; Kris, M. G.; Ginsberg, M. S.; Henry, R.; Jones, J.; Tyson, L.; Dunne, M.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Phase 1 study of 10-propargyl-10-deazaaminopterin (PDX) plus docetaxel or paclitaxel in patients with advanced cancer
    Meeting Abstract

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Sharma, S.; Gomez, J.; Kris, M. G.; Ginsberg, M.; Baez, V.; Henry, R.; Tyson, L.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • 10-Propargyl-10-deazaaminopterin: An antifolate with activity in patients with previously treated non-small cell lung cancer
    Journal Article

    Krug, L. M.; Azzoli, C. G.; Kris, M. G.; Miller, V. A.; Khokhar, N. Z.; Tong, W.; Ginsberg, M. S.; Venkatraman, E.; Tyson, L.; Pizzo, B.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save